Barbara Cordell

Introduction

Barbara Cordell is a notable inventor based in Palo Alto, California, recognized for her extensive contributions to the field of medical research with a remarkable portfolio of 26 patents. Her work primarily focuses on innovative treatments for neurological diseases, particularly Alzheimer's disease, making a significant impact on the scientific community.

Latest Patents

Among her latest innovations is a patent regarding the "Inhibition of Aβ production by β-secretase BACE2." This groundbreaking invention harnesses the unique properties of BACE2, a homolog of β-secretase, which stimulates the processing of amyloid precursor protein (APP) through a non-amyloidogenic pathway. This discovery offers methods to identify modulators that can suppress Aβ production, presenting potential treatments for Alzheimer's disease and other related neurological disorders.

Another significant patent involves "β-secretase and modulation of β-secretase activity." This innovation describes a novel β-secretase, including the methods for its partial purification and its application in screening for potential drug candidates targeting Alzheimer's and other neurological conditions. The novel β-secretase boasts a molecular weight range of approximately 32-39 kDa or 22-26 kDa, depending on the context, revealing its promising role in future therapies.

Career Highlights

Barbara Cordell has had a distinguished career, including pivotal roles at Scios Inc. and Scios Nova, Inc., where she contributed her expertise and innovative ideas to advancing medical research. Her work has been instrumental in unraveling the complexities of Alzheimer’s disease and seeking effective treatment modalities.

Collaborations

Throughout her career, Barbara has collaborated with several esteemed professionals, including James W Schilling, Jr., and Robert T White. These collaborations have enriched her research and expanded the potential impact of her patents in the medical field, showcasing the power of teamwork in scientific advancements.

Conclusion

Barbara Cordell's impressive body of work and her commitment to addressing critical health issues position her as a leading inventor in the domain of neurological disease research. With her innovative patents and collaborative spirit, she continues to push the boundaries of science, offering hope for effective treatments for Alzheimer's disease and other neurological disorders. Her contributions not only reflect her dedication but also inspire future generations of scientists and inventors in the field.